Scandinavian Chemotech Ab Stock Net Income
| CMOTEC-B | SEK 1.66 0.09 5.14% |
Scandinavian ChemoTech AB fundamentals help investors to digest information that contributes to Scandinavian ChemoTech's financial success or failures. It also enables traders to predict the movement of Scandinavian Stock. The fundamental analysis module provides a way to measure Scandinavian ChemoTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Scandinavian ChemoTech stock.
Scandinavian |
Scandinavian ChemoTech AB Company Net Income Analysis
Scandinavian ChemoTech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Scandinavian ChemoTech Net Income | (17.74 M) |
Most of Scandinavian ChemoTech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scandinavian ChemoTech AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Scandinavian ChemoTech AB reported net income of (17.74 Million). This is 105.2% lower than that of the Healthcare sector and 125.33% lower than that of the Biotechnology industry. The net income for all Sweden stocks is 103.11% higher than that of the company.
Scandinavian Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scandinavian ChemoTech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scandinavian ChemoTech could also be used in its relative valuation, which is a method of valuing Scandinavian ChemoTech by comparing valuation metrics of similar companies.Scandinavian ChemoTech is currently under evaluation in net income category among its peers.
Scandinavian Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.51 | |||
| Operating Margin | (48.69) % | |||
| Current Valuation | 68.38 M | |||
| Shares Outstanding | 10.64 M | |||
| Shares Owned By Insiders | 26.03 % | |||
| Shares Owned By Institutions | 3.32 % | |||
| Price To Book | 8.87 X | |||
| Price To Sales | 159.69 X | |||
| Revenue | 49 K | |||
| Gross Profit | 2.86 M | |||
| EBITDA | (20.02 M) | |||
| Net Income | (17.74 M) | |||
| Cash And Equivalents | 5.62 M | |||
| Cash Per Share | 1.65 X | |||
| Total Debt | 53 K | |||
| Debt To Equity | 2.10 % | |||
| Current Ratio | 7.09 X | |||
| Book Value Per Share | 0.79 X | |||
| Cash Flow From Operations | (19.18 M) | |||
| Earnings Per Share | (2.19) X | |||
| Beta | 1.56 | |||
| Market Capitalization | 113.35 M | |||
| Total Asset | 25.81 M | |||
| Net Asset | 25.81 M |
About Scandinavian ChemoTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Scandinavian ChemoTech AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scandinavian ChemoTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scandinavian ChemoTech AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.